Quinoxaline,1,4-dioxide

Modify Date: 2025-08-26 07:32:28

Quinoxaline,1,4-dioxide Structure
Quinoxaline,1,4-dioxide structure
Common Name Quinoxaline,1,4-dioxide
CAS Number 2423-66-7 Molecular Weight 162.14500
Density 1.3264 (rough estimate) Boiling Point 288.82 °C (rough estimate)
Molecular Formula C8H6N2O2 Melting Point 216 °C(dec.)
MSDS N/A Flash Point N/A

 Names

Name 4-oxidoquinoxalin-1-ium 1-oxide
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.3264 (rough estimate)
Boiling Point 288.82 °C (rough estimate)
Melting Point 216 °C(dec.)
Molecular Formula C8H6N2O2
Molecular Weight 162.14500
Exact Mass 162.04300
PSA 50.92000
LogP 1.69680

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
VD2275000
CHEMICAL NAME :
Quinoxaline, 1,4-dioxide
CAS REGISTRY NUMBER :
2423-66-7
LAST UPDATED :
199512
DATA ITEMS CITED :
11
MOLECULAR FORMULA :
C8-H6-N2-O2
MOLECULAR WEIGHT :
162.16
WISWESSER LINE NOTATION :
T66 BN ENJ BO EO

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2970 mg/kg/12D-I
TOXIC EFFECTS :
Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Primate - monkey
DOSE/DURATION :
1500 mg/kg/3D-I
TOXIC EFFECTS :
Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
5400 mg/kg/77W-C
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Sense Organs and Special Senses (Olfaction) - tumors Liver - tumors

MUTATION DATA

TYPE OF TEST :
Sister chromatid exchange
TEST SYSTEM :
Rodent - hamster Lung
DOSE/DURATION :
20 mg/L
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 139,199,1984

 Safety Information

HS Code 2933990090

 Synthetic Route

 Customs

HS Code 2933990090
Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 Synonyms

Grofas
quinoxaline N,N'-dioxide
Quindoxin
Quinoxaline dioxide
Celbar
BAY-Va 9391
benzopyrazine N,N'-dioxide
quinoxaline 1,4-bis-N-oxide
Quinoxaline di-N-oxide
USAF H-1
Chindoxin [Czech]
quinoxaline 1,4-di-N-oxide
Quinoxaline,1,4-dioxide
Bayo N-Ox
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here


Get all suppliers and price by the below link:

Quinoxaline,1,4-dioxide suppliers

Quinoxaline,1,4-dioxide price

Related Compounds: More...
2-(dihydroxymethyl)quinoxaline 1,4-dioxide
76286-62-9
2-Dimethoxymethyl-quinoxaline 1,4-dioxide
32065-66-0
2,3-bis(chloromethyl)quinoxaline 1,4-dioxide
33299-08-0
2-acetoxymethyl-3-methyl-quinoxaline 1,4-dioxide
10103-90-9
2,3-BIS(ACETOXYMETHYL)QUINOXALINE 1,4-DIOXIDE
10103-89-6
2,3-BIS(HYDROXYMETHYL)QUINOXALINE-1,4-DIOXIDE
53689-24-0
6-methoxyquinoxaline 1,4-dioxide
39266-92-7
Quinoxaline-2-carboxaldehyde-1,4-dioxide hydrate
76285-35-3
6-methoxy-2-methyl-3-[(methyl-oxy-imino)-methyl]-quinoxaline 1,4-dioxide
62018-33-1
N-(2-ethylhexyl)-3-(2-methoxyethyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-7-carboxamide
892270-88-1
2,4-dioxo-N-phenethyl-3-(p-tolyl)-1,2,3,4-tetrahydroquinazoline-7-carboxamide
892276-32-3
1-(2-chlorobenzyl)-3-(2,4-dimethoxyphenyl)-6,7-dihydro-1H-cyclopenta[4,5]thieno[2,3-d]pyrimidine-2,4(3H,5H)-dione
687583-72-8
3-(5-{[(2,4-dimethylphenyl)methyl]sulfanyl}-3-oxo-2H,3H-imidazo[1,2-c]quinazolin-2-yl)-N-[(2-methoxyphenyl)methyl]propanamide
1037289-03-4
3-(5-{[(3-chlorophenyl)methyl]sulfanyl}-3-oxo-2H,3H-imidazo[1,2-c]quinazolin-2-yl)-N-[(2-methoxyphenyl)methyl]propanamide
1037289-04-5
2-(4-(Dimethylamino)phenyl)acetyl chloride
39889-72-0
2-(Oxiran-2-yl)oxolane
1549125-77-0
3-(5-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxo-2H,3H-imidazo[1,2-c]quinazolin-2-yl)-N-(2-phenylethyl)propanamide
1037289-05-6
1-(Chloroacetyl)-4-[(5-chlorothien-2-yl)methyl]piperazine hydrochloride
1051366-60-9
(T-4)-[I+/--(Diphenylphosphino-I masculineP)benzenemethanol]trihydroboron
954422-32-3